RTW Biotech Opportunities Ltd
RTWFF
$1.30
-$0.03-2.26%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.44M | 1.44M | 1.14M | 1.14M | 943.50K |
| Total Revenue | 1.44M | 1.44M | 1.14M | 1.14M | 943.50K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.44M | 1.44M | 1.14M | 1.14M | 943.50K |
| SG&A Expenses | 2.25M | 2.25M | 1.59M | 1.59M | 1.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 327.40K | 327.40K | 226.50K | 226.50K | 117.40K |
| Total Operating Expenses | 2.75M | 2.75M | 1.93M | 1.93M | 1.76M |
| Operating Income | -1.32M | -1.32M | -789.80K | -789.80K | -811.60K |
| Income Before Tax | 42.91M | 42.91M | 25.35M | 25.35M | 16.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.91M | 42.91M | 25.35M | 25.35M | 16.25M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.91M | 42.91M | 25.35M | 25.35M | 16.25M |
| EBIT | -1.32M | -1.32M | -789.80K | -789.80K | -811.60K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.13 | 0.13 | 0.12 | 0.12 | 0.08 |
| Normalized Basic EPS | 0.06 | 0.06 | -0.02 | -0.02 | -0.01 |
| EPS Diluted | 0.13 | 0.13 | 0.12 | 0.12 | 0.08 |
| Normalized Diluted EPS | 0.06 | 0.06 | -0.02 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 335.71M | 335.71M | 210.64M | 210.64M | 212.39M |
| Average Diluted Shares Outstanding | 335.71M | 335.71M | 210.64M | 210.64M | 212.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
